These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 29146657)
1. A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. Glaysher MA; Mohanaruban A; Prechtl CG; Goldstone AP; Miras AD; Lord J; Chhina N; Falaschetti E; Johnson NA; Al-Najim W; Smith C; Li JV; Patel M; Ahmed AR; Moore M; Poulter N; Bloom S; Darzi A; Le Roux C; Byrne JP; Teare JP BMJ Open; 2017 Nov; 7(11):e018598. PubMed ID: 29146657 [TBL] [Abstract][Full Text] [Related]
2. Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients. Forner PM; Ramacciotti T; Farey JE; Lord RV Obes Surg; 2017 Dec; 27(12):3306-3313. PubMed ID: 29018990 [TBL] [Abstract][Full Text] [Related]
3. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Gersin KS; Keller JE; Stefanidis D; Simms CS; Abraham DD; Deal SE; Kuwada TS; Heniford BT Surg Innov; 2007 Dec; 14(4):275-8. PubMed ID: 18178916 [TBL] [Abstract][Full Text] [Related]
4. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study. Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045 [TBL] [Abstract][Full Text] [Related]
5. Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes. Kral J; Benes M; Lanska V; Macinga P; Drastich P; Spicak J; Hucl T Obes Surg; 2024 May; 34(5):1407-1414. PubMed ID: 38436919 [TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Schouten R; Rijs CS; Bouvy ND; Hameeteman W; Koek GH; Janssen IM; Greve JW Ann Surg; 2010 Feb; 251(2):236-43. PubMed ID: 19858703 [TBL] [Abstract][Full Text] [Related]
7. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids. Glaysher MA; Ward J; Aldhwayan M; Ruban A; Prechtl CG; Fisk HL; Chhina N; Al-Najim W; Smith C; Klimowska-Nassar N; Johnson N; Falaschetti E; Goldstone AP; Miras AD; Byrne JP; Calder PC; Teare JP Clin Nutr; 2021 Apr; 40(4):2343-2354. PubMed ID: 33131909 [TBL] [Abstract][Full Text] [Related]
8. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Patel SR; Hakim D; Mason J; Hakim N Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926 [TBL] [Abstract][Full Text] [Related]
9. Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol. Murphy R; Evennett NJ; Clarke MG; Robinson SJ; Humphreys L; Jones B; Kim DD; Cutfield R; Plank LD; Hammodat H; Booth MW BMJ Open; 2016 Jul; 6(7):e011416. PubMed ID: 27377635 [TBL] [Abstract][Full Text] [Related]